Jason Raleigh Nunn
CIK 1444319 · last filed 2025-10-14
Jason Raleigh Nunn is a corporate insider who has filed 41 SEC Form 4 insider transactions across 6 companies since 2013. The most recent filing shows the insider bought $1.2M of ZBIO on Oct 14, 2025. Across all open-market trades the lifetime net is +$16.2M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $23.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$23.27M
6
41
$16.20M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ZBIO | Director | 1,173,395 | $19.80 | $23.23M | $16.20M | 3 | 2025-10-14 |
| Regulus Therapeutics Inc. (RGLS) Delisted | Director | 0 | $8.16 | $0 | $0 | 10 | 2025-06-27 |
| TRVN | Director | 4,271 | $0.01 | $47 | $0 | 11 | 2024-06-14 |
| DERM | Director | 6,000 | $6.34 | $38.0K | $0 | 7 | 2019-06-14 |
| TriVascular Technologies, Inc. (TRIV) Delisted | Director | — | — | — | $0 | 1 | 2015-05-27 |
| HYPERION THERAPEUTICS INC (HPTX) Delisted | Director | — | — | — | $0 | 1 | 2013-05-01 |
Recent Filings
41 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-14 | ZBIO | Buy (P) | +63,158 | $1.20M | EDGAR |
| 2025-06-27 | Regulus Therapeutics Inc. (RGLS) Delisted | Disp (D) | −62,500 | $0 | EDGAR |
| 2025-06-12 | ZBIO | Grant (A) | — | $0 | EDGAR |
| 2025-04-30 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | +62,500 | $0 | EDGAR |
| 2024-09-16 | ZBIO | Mixed | +3,056,801 | $15.00M | EDGAR |
| 2024-06-14 | TRVN | Grant (A) | — | $0 | EDGAR |
| 2024-05-21 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-17 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-08-14 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-20 | TRVN | Grant (A) | — | $0 | EDGAR |